BCWORLD PHARM. Co. Ltd Cash Flow Reinvestment Rate

Latest as of September 2025: 1.95x

BCWORLD PHARM. Co. Ltd cash flow reinvestment rate. BCWORLD PHARM. Co. Ltd (200780) has a Cash Flow Reinvestment Rate of 1.95x as of September 2025, reinvesting ₩2.79 Billion (capex ₩1.63 Billion plus investments ₩-1.16 Billion) from operating cash flow of ₩1.43 Billion. See BCWORLD PHARM. Co. Ltd (200780) flexibility index to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

1.95x
(Capex + Investments) / Operating CF

Total Reinvested

₩2.79 Billion
Capex + Investments

Operating Cash Flow

₩1.43 Billion
KRW

Capital Expenditures

₩1.63 Billion
KRW

Cash Flow Reinvestment Rate of BCWORLD PHARM. Co. Ltd (2015–2024)

Cash flow reinvestment rate of BCWORLD PHARM. Co. Ltd from 2015 to 2024. Historical reinvestment intensity for BCWORLD PHARM. Co. Ltd across 8 annual periods. Explore 200780 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

BCWORLD PHARM. Co. Ltd Cash Flow Reinvestment Rate by Year (2015–2024)

BCWORLD PHARM. Co. Ltd cash flow reinvestment rate by year from 2015 to 2024. Year-by-year capital reinvestment analysis for BCWORLD PHARM. Co. Ltd. For the full cash flow conversion analysis, see BCWORLD PHARM. Co. Ltd cash flow conversion.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2024 0.88x ₩3.55 Billion ₩4.04 Billion ₩2.41 Billion ▲ +48.2%
2023 0.59x ₩6.47 Billion ₩10.94 Billion ₩2.71 Billion ▼ -42.5%
2022 1.03x ₩7.08 Billion ₩6.88 Billion ₩6.22 Billion ▼ -42.8%
2019 1.80x ₩21.76 Billion ₩12.11 Billion ₩21.32 Billion ▼ -69.1%
2018 5.81x ₩31.03 Billion ₩5.34 Billion ₩29.92 Billion ▲ +176.2%
2017 2.10x ₩16.62 Billion ₩7.90 Billion ₩16.58 Billion ▼ -96.0%
2016 52.54x ₩12.80 Billion ₩243.66 Million ₩12.56 Billion ▲ +1726.7%
2015 2.88x ₩25.26 Billion ₩8.78 Billion ₩25.26 Billion —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow